Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa
about
The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in AfricaCervical cancer prevention and treatment research in Africa: a systematic review from a public health perspectiveEvaluation of a Smartphone-Based Training Strategy Among Health Care Workers Screening for Cervical Cancer in Northern Tanzania: The Kilimanjaro Method.Knowledge, awareness and attitudes about cervical cancer among women attending or not an HIV treatment center in Lao PDR.Improving diagnostic capability for HPV disease internationally within the NIH-NIAID Division of AIDS Clinical Trial NetworksCervical Abnormalities in South African Women Living With HIV With High Screening and Referral Rates.Clinical performance of digital cervicography and cytology for cervical cancer screening in HIV-infected women in Lusaka, ZambiaAccuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in KenyaHuman papillomavirus (HPV) testing on self-collected specimens: perceptions among HIV positive women attending rural and urban clinics in South AfricaEvaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South AfricaUtilization of cervical cancer screening services and trends in screening positivity rates in a 'screen-and-treat' program integrated with HIV/AIDS care in Zambia.Cost evaluation of reproductive and primary health care mobile service delivery for women in two rural districts in South Africa.High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women.Screening tests: a review with examplesThe Need for Cervical Cancer Control in HIV-Positive and HIV-Negative Women from Romania by Primary Prevention and by Early Detection Using Clinically Validated HPV/DNA TestsAcceptability and Accuracy of Cervical Cancer Screening Using a Self-Collected Tampon for HPV Messenger-RNA Testing among HIV-Infected Women in South AfricaEvaluation of Cervical Cancer Screening Programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV StatusCost-effectiveness of using the Cervex-Brush (broom) compared to the elongated spatula for collection of conventional cervical cytology samples within a high-burden HIV setting: a model-based analysis.Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa.Distribution of human papillomaviruses and bacterial vaginosis in HIV positive women with abnormal cytology in Mombasa, KenyaClinical Performance Validation of 4 Point-of-Care Cervical Cancer Screening Tests in HIV-Infected Women in Zambia.Risk factors for cervical precancer detection among previously unscreened HIV-infected women in Western Kenya.A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya.A review of screening strategies for cervical cancer in human immunodeficiency virus-positive women in sub-Saharan Africa.Cervical cancer screening in rural South Africa among HIV-infected migrant farm workers and sex workersCervical cancer control in HIV-infected women: Past, present and future.Malignancies in women with HIV infection.Estimating the costs of cervical cancer screening in high-burden Sub-Saharan African countries.Performance of careHPV for detecting high-grade cervical intraepithelial neoplasia among women living with HIV-1 in Burkina Faso and South Africa: HARP study.Implementing a Fee-for-Service Cervical Cancer Screening and Treatment Program in Cameroon: Challenges and Opportunities.Use of visual inspection with acetic acid, Pap smear, or high-risk human papillomavirus testing in women living with HIV/AIDS for posttreatment cervical cancer screening: same tests, different priorities.Performance of the Cellslide® automated liquid-based cytology system amongst HIV-positive womenInfluence of knowledge of human immunodeficiency virus serostatus on accuracy of cervical cytologic diagnosis.Role of p16 testing in cervical cancer screening among HIV-infected womenPrevention of human papillomavirus (HPV)-related tumors in people living with human immunodeficiency virus (HIV).Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women.Is It Time to Move Beyond Visual Inspection With Acetic Acid for Cervical Cancer Screening?Detection of hypermethylated genes as markers for cervical screening in women living with HIVProtocol for the study of cervical cancer screening technologies in HIV-infected women living in Rwanda
P2860
Q26799584-8DB0BA70-009B-4506-BA12-4FB76642EFDEQ28601706-7B1AF8A4-3FD1-4DB5-A8DF-A53A890FA2BDQ33455639-BF7EC0F6-43CE-4311-BB97-E659FD744C09Q33591557-0184BE19-B505-4746-B827-987B0C92A90FQ33595423-408B8517-46C7-4E73-AB88-C5CCE173310EQ33859622-2A1A6430-76AC-4321-BF52-C35650B7EE14Q34173391-7824DFB1-0A56-4C84-BE53-5C68E45A3166Q34429237-B4C600CE-70C4-4FE3-8C2F-BECA4ACDB9A4Q34496820-36F05FBF-4A26-4A0F-813F-8014FFA9A488Q34743814-81552473-C4EE-4F95-94E8-7C253C47DD9AQ34994799-FD0B5DB0-F1B0-4DCC-A2F6-BB15BEA89044Q35159171-4736525A-F0EF-4B60-9B03-D86AECA720D8Q35186321-FA19C86C-EC31-4C05-8185-DC09430A942EQ35302443-95F808DE-09F3-417A-8E20-77D88C794AE6Q35317799-9D74ED31-E42C-4B85-8756-83952B6679E7Q35694602-D82AF85F-DA4C-4AEB-AD40-DA5053423835Q35762277-06FB943D-D6FB-40A7-80D2-32986BD80A8BQ35787542-83123A9D-8236-4269-AF32-A798D1C3CD1BQ35834645-D5ED9482-A304-48A0-A23F-77A2AE54F40DQ35841702-EB9FA901-5EE7-4004-A2DF-90342E08775DQ36769394-7EC7E4F2-15FD-4724-89C8-A03C91703523Q37037325-654C98EC-27E6-4D23-BDC0-990F559BB9C5Q37340516-BD6482B4-05BB-4581-830B-F2923A7DE21CQ37630256-7F6EE1C8-A191-4E8A-992F-92AA487433F6Q37632090-CCE6BFF2-96F5-4750-9A31-B66077B2E80CQ37643110-1CEB3EB8-B373-446A-8EB4-D4A94A7AD65CQ38640490-6013646E-E45E-4A64-ADD5-BD683B6E7BA6Q39010145-FB3CDAEA-3FF4-47ED-9E46-939A9D01A108Q39285506-4F16B902-D323-4AB7-94A2-D2A0100D6C55Q39443867-9AE0F108-57C2-4F63-9821-07BEAD923EC6Q40201585-8ECDB5D1-9D5D-46D6-AB66-2D5D7490AD1EQ40400577-AE925200-D598-48A0-9DD4-E9A7F19BE664Q40940849-DF6A7CFE-C81E-479D-B6C5-B94623D5035DQ41722629-B2B96A0A-052D-436D-A1F3-F348E8399FD3Q41986617-FCDA2316-B843-416F-85AA-C590F96F91E4Q45326416-04EF1B29-9751-4521-AFE3-7A92BE6DCABDQ47599029-B94CB540-A016-4495-8D92-97A792580E91Q55409645-5261E875-6ED8-4125-97F3-2D693507CD0FQ56941300-B371597E-3208-4281-8213-5F40368310A6Q58800228-567D2179-50C4-41E5-BEC0-EAD5F5F2BECC
P2860
Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Validation of cervical cancer ...... from Johannesburg South Africa
@ast
Validation of cervical cancer ...... from Johannesburg South Africa
@en
Validation of cervical cancer ...... from Johannesburg South Africa
@nl
type
label
Validation of cervical cancer ...... from Johannesburg South Africa
@ast
Validation of cervical cancer ...... from Johannesburg South Africa
@en
Validation of cervical cancer ...... from Johannesburg South Africa
@nl
prefLabel
Validation of cervical cancer ...... from Johannesburg South Africa
@ast
Validation of cervical cancer ...... from Johannesburg South Africa
@en
Validation of cervical cancer ...... from Johannesburg South Africa
@nl
P2093
P2860
P50
P1433
P1476
Validation of cervical cancer ...... from Johannesburg South Africa
@en
P2093
Avril Swarts
Bruce Allan
Jennifer S Smith
Mark Faesen
Michael G Hudgens
Nomtha Mayisela
Pam Michelow
Simon Levin
Sophie Williams
P2860
P304
P356
10.1371/JOURNAL.PONE.0053494
P407
P577
2013-01-11T00:00:00Z